Osteoporosis is one of the most common conditions affecting the elderly in the eastern and western hemispheres. With better health care and better standards of living, the proportion of older people in the populations of Asian countries, as in Western countries, is increasing. In the practice of orthopedics, this results in an increased incidence of osteoporosis and associated fractures. To illustrate this problem, from 1966 onwards the incidence of hip fractures increased threefold in Hong Kong20.
This condition is likely to remain prevalent, and prevention of excessive occurrence and concomitant complications is the only option to control the problem. Dietary calcium intake among elderly Chinese people in Hong Kong has been found to be much lower than that of whites due to the lack of consumption of dairy products. The average daily calcium intake of an individual in Hong Kong was about ¼ that of his British counterparts. In some cases, calcium supplements may be necessary, but other factors, such as physical activity, may be just as important.
Numerous studies have been carried out on white populations regarding the incidence of osteoporosis and disability and the resulting costs. Most of these reports were based on analysis of the hip and other long bone fractures. Vertebral fractures resulting from osteoporosis are common and have been shown to increase exponentially with age. In the United States, 25% of women age 70 or older and 50% of women age 80 or older have signs of spinal fractures. In Hong Kong, the figures are comparable to data for white women.
Measuring bone density as a screening procedure for the general population is too expensive and can only be recommended in high-risk groups. This may include women who have had premature menopause, in whom hormone replacement therapy may be beneficial. Cheaper biochemical methods for community screening (urinary hydroxyproline and calcium: creatinine ratios) have been suggested.
Research Article: Journal of Bioanalysis & Biomedicine
Research Article: Journal of Bioanalysis & Biomedicine
Short Communication: Journal of Bioanalysis & Biomedicine
Short Communication: Journal of Bioanalysis & Biomedicine
Review Article: Journal of Bioanalysis & Biomedicine
Review Article: Journal of Bioanalysis & Biomedicine
Research Article: Journal of Bioanalysis & Biomedicine
Research Article: Journal of Bioanalysis & Biomedicine
Special Issue Article: Journal of Bioanalysis & Biomedicine
Special Issue Article: Journal of Bioanalysis & Biomedicine
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Keynote: Journal of Bioanalysis & Biomedicine
Keynote: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report